Media - Abzena

Events

WEBINAR- Oligonucleotide ADC design and development – an emerging field building on the success of ADCs in cancer

18 February 2021

Register for our webinar here. Antibody-drug conjugates (ADCs) are an established class of biopharmaceuticals with[...] Read more

Antibody engineering & therapeutics virtual 2020

14 December 2020

Abzena will be attending the virtual Antibody engineering & therapeutics event from 14th-16th December 2020. If you[...] Read more

References

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more

News

Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates,[...] Read more

Kimball Hall promoted to President and appointed to the Abzena board

Abzena, a Global Partner Research Organization for integrated bench to bedside solutions for biologics, complex chemistry[...] Read more

Posts

Interested in our services? Get In Touch